Literature DB >> 26322418

Primary outgrowth cultures are a reliable source of human pancreatic stellate cells.

Song Han1, Daniel Delitto1, Dongyu Zhang1, Heather L Sorenson2, George A Sarosi1,3, Ryan M Thomas1,3, Kevin E Behrns1, Shannon M Wallet2, Jose G Trevino1, Steven J Hughes1.   

Abstract

Recent advances demonstrate a critical yet poorly understood role for the pancreatic stellate cell (PSC) in the pathogenesis of chronic pancreatitis (CP) and pancreatic cancer (PC). Progress in this area has been hampered by the availability, fidelity, and/or reliability of in vitro models of PSCs. We examined whether outgrowth cultures from human surgical specimens exhibited reproducible phenotypic and functional characteristics of PSCs. PSCs were cultured from surgical specimens of healthy pancreas, CP and PC. Growth dynamics, phenotypic characteristics, soluble mediator secretion profiles and co-culture with PC cells both in vitro and in vivo were assessed. Forty-seven primary cultures were established from 52 attempts, demonstrating universal α-smooth muscle actin and glial fibrillary acidic protein but negligible epithelial surface antigen expression. Modification of culture conditions consistently led to cytoplasmic lipid accumulation, suggesting induction of a quiescent phenotype. Secretion of growth factors, chemokines and cytokines did not significantly differ between donor pathologies, but did evolve over time in culture. Co-culture of PSCs with established PC cell lines resulted in significant changes in levels of multiple secreted mediators. Primary PSCs co-inoculated with PC cells in a xenograft model led to augmented tumor growth and metastasis. Therefore, regardless of donor pathology, outgrowth cultures produce PSCs that demonstrate consistent growth and protein secretion properties. Primary cultures from pancreatic surgical specimens, including malignancies, may represent a reliable source of human PSCs.

Entities:  

Mesh:

Year:  2015        PMID: 26322418     DOI: 10.1038/labinvest.2015.117

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  30 in total

1.  Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis.

Authors:  M V Apte; P S Haber; S J Darby; S C Rodgers; G W McCaughan; M A Korsten; R C Pirola; J S Wilson
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

Review 2.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 3.  Pancreatic disease in 2014: Pancreatic fibrosis and standard diagnostics.

Authors:  Güralp O Ceyhan; Helmut Friess
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-01-06       Impact factor: 46.802

4.  Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness.

Authors:  Enza Lonardo; Javier Frias-Aldeguer; Patrick C Hermann; Christopher Heeschen
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

5.  Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis: deactivation is induced by matrigel and N-acetylcysteine.

Authors:  Ralf Jesnowski; Daniel Fürst; Jörg Ringel; Ying Chen; Andrea Schrödel; Jörg Kleeff; Armin Kolb; Wolfgang D Schareck; Matthias Löhr
Journal:  Lab Invest       Date:  2005-10       Impact factor: 5.662

6.  Pancreatic stellate cells: partners in crime with pancreatic cancer cells.

Authors:  Alain Vonlaufen; Swapna Joshi; Changfa Qu; Phoebe A Phillips; Zhihong Xu; Nicole R Parker; Cheryl S Toi; Romano C Pirola; Jeremy S Wilson; David Goldstein; Minoti V Apte
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

Review 7.  Pancreatic stellate cells--role in pancreas cancer.

Authors:  Max G Bachem; Shaoxia Zhou; Karin Buck; Wilhelm Schneiderhan; Marco Siech
Journal:  Langenbecks Arch Surg       Date:  2008-01-17       Impact factor: 3.445

8.  Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture.

Authors:  M V Apte; P S Haber; T L Applegate; I D Norton; G W McCaughan; M A Korsten; R C Pirola; J S Wilson
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

9.  Identification, culture, and characterization of pancreatic stellate cells in rats and humans.

Authors:  M G Bachem; E Schneider; H Gross; H Weidenbach; R M Schmid; A Menke; M Siech; H Beger; A Grünert; G Adler
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

10.  Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling.

Authors:  Christian Pilarsky; Ole Ammerpohl; Bence Sipos; Edgar Dahl; Arndt Hartmann; Axel Wellmann; Till Braunschweig; Matthias Löhr; Ralf Jesenofsky; Ralf Jesnowski; Helmut Friess; Moritz Nicolas Wente; Glen Kristiansen; Beatrix Jahnke; Axel Denz; Felix Rückert; Hans K Schackert; Günter Klöppel; Holger Kalthoff; Hans Detlev Saeger; Robert Grützmann
Journal:  J Cell Mol Med       Date:  2008-02-24       Impact factor: 5.310

View more
  17 in total

1.  BET inhibitors block pancreatic stellate cell collagen I production and attenuate fibrosis in vivo.

Authors:  Krishan Kumar; Brian T DeCant; Paul J Grippo; Rosa F Hwang; David J Bentrem; Kazumi Ebine; Hidayatullah G Munshi
Journal:  JCI Insight       Date:  2017-02-09

2.  Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment.

Authors:  Daniel Delitto; Andrea E Delitto; Bayli B DiVita; Kien Pham; Song Han; Emily R Hartlage; Brittney N Newby; Michael H Gerber; Kevin E Behrns; Lyle L Moldawer; Ryan M Thomas; Thomas J George; Todd M Brusko; Clayton E Mathews; Chen Liu; Jose G Trevino; Steven J Hughes; Shannon M Wallet
Journal:  Cancer Res       Date:  2016-11-18       Impact factor: 12.701

3.  Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model.

Authors:  Weijing Cai; Ranjala Ratnayake; Michael H Gerber; Qi-Yin Chen; Yichao Yu; Hartmut Derendorf; Jose G Trevino; Hendrik Luesch
Journal:  Invest New Drugs       Date:  2018-08-03       Impact factor: 3.850

4.  Pancreatic Tumor Microenvironment.

Authors:  Kai Wang; Hong He
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Explant culture of sarcoma patients' tissue.

Authors:  Roman Muff; Sander M Botter; Knut Husmann; Joelle Tchinda; Philomina Selvam; Franziska Seeli-Maduz; Bruno Fuchs
Journal:  Lab Invest       Date:  2016-04-25       Impact factor: 5.662

6.  Nicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer Microenvironment.

Authors:  Daniel Delitto; Dongyu Zhang; Song Han; Brian S Black; Andrea E Knowlton; Adrian C Vlada; George A Sarosi; Kevin E Behrns; Ryan M Thomas; Xiaomin Lu; Chen Liu; Thomas J George; Steven J Hughes; Shannon M Wallet; Jose G Trevino
Journal:  Clin Cancer Res       Date:  2015-12-14       Impact factor: 12.531

7.  Regulation of pancreatic stellate cell activation by Notch3.

Authors:  Haiyan Song; Yuxiang Zhang
Journal:  BMC Cancer       Date:  2018-01-05       Impact factor: 4.430

Review 8.  Biology of pancreatic stellate cells-more than just pancreatic cancer.

Authors:  Pawel E Ferdek; Monika A Jakubowska
Journal:  Pflugers Arch       Date:  2017-04-05       Impact factor: 3.657

Review 9.  From tumor microenvironment communicants to biomarker discovery: Selectively packaged extracellular vesicular cargoes in pancreatic cancer.

Authors:  Song Han; Patrick Underwood; Steven J Hughes
Journal:  Cytokine Growth Factor Rev       Date:  2020-01-11       Impact factor: 7.638

10.  The pancreatic tumor microenvironment drives changes in miRNA expression that promote cytokine production and inhibit migration by the tumor associated stroma.

Authors:  Song Han; David H Gonzalo; Michael Feely; Daniel Delitto; Kevin E Behrns; Mark Beveridge; DongYu Zhang; Ryan Thomas; Jose G Trevino; Thomas D Schmittgen; Steven J Hughes
Journal:  Oncotarget       Date:  2016-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.